COVID-19–Associated Invasive Fungal Infections: Expert Guidance on Cases From the Community

Access Activity

Overview / Abstract:

Target Audience
This activity is directed to physicians with specialties in infectious diseases, pulmonary/critical care medicine, and pathology/laboratory medicine as well as other healthcare providers who care for patients with severe COVID-19.

Program Overview
Patients with severe COVID-19 who require mechanical ventilation are at increased risk for invasive fungal infections (IFIs), which increase morbidity and mortality. As part of a CDC Cooperative agreement, the faculty for the COVID-19–associated Fungal Infections Educational Initiative (https://covidandfungus.org/) have developed a series of tools for diagnosing and managing these IFIs. In this interactive, case-based activity, expert faculty members weigh in on challenging COVID-19–associated IFI cases submitted by community clinicians. The faculty members illustrate how to address IFI diagnostic and management challenges in order to optimize patient outcomes.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Identify patients with COVID-19 who are at risk for COVID-19–associated pulmonary aspergillosis (CAPA) and other COVID-19–associated invasive fungal infections (CA-IFIs)
Perform appropriate diagnostic tests for CAPA and CA-IFIs in at-risk patients with COVID-19
Select appropriate antifungal therapy for patients with CA-IFIs
Optimize the pharmacologic aspects of antifungal therapy in patients with CA-IFIs

Expiration

Aug 23, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.5

Accreditation

ACCME, ACPE, ANCC

Presenters / Authors / Faculty

George R Thompson, III, MD, FACP
Dimitrios Kontoyiannis, MD, ScD, FACP, FIDSA, PhD Hon, FECMM, FAAM
Minh-Hong Thi Nguyen, MD

Sponsors / Supporters / Grant Providers

This educational initiative was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (CFD-RFA-CK20-2003) to the University of Alabama at Birmingham. The University of Alabama at Birmingham is collaborating with the Mycoses Study Group Education & Research Consortium and Terranova Medica, LLC, on this initiative.

Keywords / Search Terms

Relias LLC Relias, Free CME, COVID-19 Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map